DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

EDINBURGH, Scotland--(BUSINESS WIRE)-- DexCom, Inc. (DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a ...

DexCom, a developer of continuous glucose monitoring systems, and certain executives were hit with a securities class action on Nov. 25 in California Southern District Court over alleged unauthorized ...

Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.

DexCom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a new personalised learning ...

Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

Automated insulin delivery systems — a continuous glucose monitor, insulin pump, and algorithm — enable athletes to manage ...

With the MetroCard retiring at the end of 2025, the OMNY system will become the only way to pay for most transit riders.

Mortality rates are high in patients with type 1 diabetes, and overweight and obesity appear to be major factors, a speaker ...